Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Regulatory News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re COVID 19; confirmed orders; investment

30 Mar 2020 07:00

RNS Number : 9509H
Integumen PLC
30 March 2020
 

AIM share code: SKIN

30 March 2020

 

Integumen PLC

 

("Integumen" or "Company")

 

Immediate production of bacteria to detect water contamination amid COVID-19 public health crisis

 

Integumen confirm c£2m confirmed orders in Q1, 2020 and invests £250,000 to ramp-up production

 

Integumen announces that due to the global COVID-19 public health crisis, and in order to meet back-orders and growing demand for water contamination detection bacteria from existing customers across Spain, Italy and China, production of Modern Water's monitoring bacteria reagent has commenced this week, six weeks ahead of the originally planned production date.

 

Further to previous notifications, enlargement of Integumen's laboratories and fit-out has commenced with the ordering of the new laboratory equipment. The bacteria is used in fixed and portable monitoring equipment, designed and manufactured by Modern Water plc to identify contamination in wastewater outlets from residential, hospital and municipal sewage treatment outflows that may contribute to the current public health crisis.

 

In addition to the c£2m of confirmed orders so far in Q1, 2020 for delivery in the current financial year, Integumen is investing £250,000, as announced in the RNS of 18 March 2020, to rapidly expand the Company's laboratories by 100% to 6,000 square feet in order to maintain the growth of Labskin and accelerate production of bacteria that is used by a range of monitoring equipment for the detection of up to 2,300 bacteria, viruses and toxins that contaminate water around the world.

 

Gerard Brandon CEO Integumen plc commented:

"In the wake of the COVID-19 public health crisis, we are grateful to local industry and research institutions such as Frozen in Time Limited and University of York, who have enabled Integumen to begin production immediately. We are now able to bring water contamination detection bacteria faster to the frontline environmental inspection teams, in crisis countries, where there is currently insufficient supply. I also want to acknowledge our team of dedicated chemical engineers, biologists, microbiologists and quality control personnel who are playing their role in making this happen.

 

"Integumen is in a strong position to provide the support for Modern Water and all their customers across the world through delivery of integrated engineering, scientific and real-time data analytical solutions in order to address this major societal and global problem in healthcare and the environment. "

 

 

Integumen plc

Gerard Brandon, CEO

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

About Integumen plc

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 

About Modern Water plc

Modern Water was established in 2006 to develop and commercialise water recovery technologies to counter water crisis problems arising from climate change and a growing global population. Having invested £20m over the last 14 years, the results comprise of a robust patent portfolio of cutting edge technology, focused on monitoring of contaminated water and decontamination of wastewater, making recycling of water more efficient. Six countries across the world have legislated that Modern Water monitoring test systems are written into their environmental protection legislation.

 

About Frozen in Time

Based in York, UK, Frozen in Time Limited has been designing and manufacturing freeze dryers for more than a quarter of a century. In that time, they fabricated machinery in a full range of sizes and specifications, for businesses of all sizes, working in all kinds of industry sectors worldwide.

 

About University of York

The University of York is a collegiate research university, located in the city of York, England. Established in 1963, the university has expanded to more than thirty departments and centres. With over £8 million of capital equipment, 2,000 square meters of laboratories, the purpose-built centre of excellence provides access to state-of-the-art bioscience technologies for external academic laboratories and commercial business users. It has all the relevant equipment needed to begin production of the water contamination detection bacteria immediately.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUWVWRRKUOURR
Date   Source Headline
2nd May 201910:51 amRNSHolding(s) in Company
2nd May 20198:18 amRNSBoard Appointment & Admission of Shares
1st May 201911:00 amRNSChanges to interests of a significant shareholder
30th Apr 20191:18 pmRNSResult of General Meeting
25th Apr 20197:01 amRNSTurner Pope Investor Evening
25th Apr 20197:00 amRNSLaunch of New Animal-Free Labskin Dandruff Test
12th Apr 20197:00 amRNSAcquisition of RinoCloud, Placing to raise £2.518m
25th Mar 20197:00 amRNSCBD tests boost procollagen and reduce irritation
21st Mar 20198:45 amRNSExercise of Warrants - Replacement
21st Mar 20197:01 amRNSExercise of Warrants
21st Mar 20197:00 amRNSLabskin:addl workspace at DHEZ Bradford University
18th Mar 20197:00 amRNSChange of Adviser
13th Mar 20194:35 pmRNSPrice Monitoring Extension
13th Mar 20197:00 amRNSExercise of Options
12th Mar 201910:51 amRNSShare Price Movement
11th Mar 20192:05 pmRNSSecond Price Monitoring Extn
11th Mar 20192:00 pmRNSPrice Monitoring Extension
5th Mar 20194:40 pmRNSSecond Price Monitoring Extn
5th Mar 20194:35 pmRNSPrice Monitoring Extension
5th Mar 20197:01 amRNSIssue of Equity
5th Mar 20197:00 amRNSAcqn of specialist equipment for Labskin's lab
25th Feb 20192:05 pmRNSSecond Price Monitoring Extn
25th Feb 20192:00 pmRNSPrice Monitoring Extension
22nd Feb 20192:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20192:00 pmRNSPrice Monitoring Extension
21st Feb 201911:05 amRNSSecond Price Monitoring Extn
21st Feb 201911:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSLabskin CBD tests
8th Feb 20197:00 amRNSRollout of Labskin AI Software as a Service begins
7th Feb 20197:00 amRNSChanges to interests of a significant shareholder
23rd Jan 20197:41 amRNSHolding(s) in Company
7th Jan 20197:00 amRNSTrading Update
18th Dec 20187:00 amRNSDivestment of TSPro GmbH
13th Dec 20187:00 amRNSLabskin-On-A-Chip
11th Dec 20181:20 pmRNSIssue of Equity
7th Dec 201812:46 pmRNSResult of Meeting
22nd Nov 20187:00 amRNSSubscription/ Placing to raise £355k, Notice of GM
15th Nov 20182:05 pmRNSSecond Price Monitoring Extn
15th Nov 20182:00 pmRNSPrice Monitoring Extension
15th Nov 20187:00 amRNSTrading Update
1st Nov 20187:00 amRNSCompletion of acq'n of interest in Cellulac plc
11th Oct 20187:00 amRNSUpdate on Placing and Subscription
27th Sep 20183:15 pmRNSUpdate :Placing&Subscription;Trading Announcement
20th Sep 20189:57 amRNSReplacement:legal demand; Placing and Subscription
19th Sep 20187:00 amRNSDetail of legal demand;Placing/Subscription update
17th Sep 20187:00 amRNSFirst laboratory-grown human-skin test service
29th Aug 20187:00 amRNSInterim Results
9th Aug 20184:34 pmRNSResult of AGM
3rd Aug 20183:22 pmRNSShare Purchase Agreement signed; Issue of shares
2nd Aug 20182:57 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.